Related Experiment Videos

Inactivation of p53 gene in human and murine osteosarcoma cells

N Chandar1, B Billig, J McMaster

  • 1Orthopaedic Research Laboratory, Allegheny-Singer Research Institute, Pittsburgh, Pennsylvania 15212.

British Journal of Cancer
|February 1, 1992
PubMed

Insights

Rearrangement of the p53 gene, particularly in its first intron, was observed in both mouse and human osteosarcoma models. This genetic alteration leads to a lack of p53 expression, suggesting its critical role in osteosarcoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a primary bone cancer with complex genetic underpinnings.
  • The p53 and retinoblastoma (Rb) tumor suppressor genes are frequently implicated in cancer development.

Purpose of the Study:

  • To investigate the structural and expression status of p53 and Rb genes in a mouse model of osteosarcoma.
  • To compare these findings with human osteosarcoma cell lines.

Main Methods:

  • Analysis of p53 and Rb gene structure and expression in a C3HOS mouse osteosarcoma model.
  • Comparative analysis using five human osteosarcoma cell lines (MG-63, G-292, Saos-2).
  • Utilized p53 genomic probes for rearrangement detection.

Main Results:

  • The p53 gene was rearranged in the mouse osteosarcoma, specifically in the first intron, resulting in undetectable p53 expression.
  • Similar p53 gene rearrangements involving the first intron were found in three of five human osteosarcoma cell lines, also leading to absent p53 expression.
  • The mouse tumor showed normal expression of Rb and c-myc genes.
  • One human cell line (Saos-2) displayed gross structural alteration in the Rb gene.

Conclusions:

  • Inactivation of the p53 gene, through rearrangement in the first intron, appears to be a significant event in osteosarcoma development.
  • First intron rearrangement of p53 is a common finding in both murine and human osteosarcomas.

Related Concept Videos